Masamichi Fukuda, MD
- 2Articles
- 3.5KReads1
- 2004–2007Active
- 12Collaborators
1 Read counts for articles published before 2020 may include some non-human traffic.
About
Masamichi Fukuda, MD, has published research focused on metabolic side effects associated with antipsychotic treatment, particularly investigating risk factors for atypical neuroleptic-induced hypertriglyceridemia and the incidence of hyperglycemia in patients treated with olanzapine. Fukuda's work spans clinical areas related to schizophrenia and schizoaffective disorders, with an emphasis on weight and metabolic changes. The publications appeared between 2004 and 2007 in Psychiatrist.com (The Journal of Clinical Psychiatry and The Primary Care Companion for CNS Disorders).
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
